Skip to main content
Premium Trial:

Request an Annual Quote

Protiveris Licenses Sensor Technologies from UT-Batelle

NEW YORK, Dec. 3 (GenomeWeb News) - Protiveris has licensed rights to sensor technologies from UT-Batelle, as part of its development of bioMEMS biochips for protein research, the Rockville, Md. Company said today.

 

The technologies, developed by scientists at Oak Ridge National Laboratory, allow users to measure biomolecular interactions with microcantilevers, the company said.   Protiveris already has biochips that use arrays of microcantilevers as biosensors.

 

Under the agreement, the company will be working with ORNL scientists to further develop this system, the VeriScan 3000.

 

"We are extremely pleased to have acquired the commercial rights to these technologies and to be working closely with Oak Ridge National Laboratory on their commercial development," Robert Menzi, Chief Operating Officer of Protiveris, said in a statement.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.